Skip to content
★ Sign in to follow
EC

Erik C. Emerson

CEO
Apimeds Pharmaceuticals US, Inc.
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 20 May 2025 for Apimeds Pharmaceuticals US, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Erik C. Emerson: trading record in brief

Only one filing by Erik C. Emerson is known so far (20 May 2025): a share grant, in Apimeds Pharmaceuticals US, Inc. That is too little to draw conclusions. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Erik C. Emerson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total

1 of 1 declaration